ストックスクリーナーアプリを入手
178.45
0.00%
0.00
プレマーケット:
178.45
前日終値:
$178.45
開ける：
$178.51
24時間の取引高:
824.70K
Relative Volume:
0.68
時価総額：
$9.35B
収益：
$1.56B
当期純損益:
$216.80M
株価収益率:
122.39
EPS:
1.458
ネットキャッシュフロー:
$206.10M
1週間 パフォーマンス:
-0.20%
1か月 パフォーマンス:
-0.01%
6か月 パフォーマンス:
+25.29%
1年 パフォーマンス:
+13.68%
1日の値動き範囲:
$178.38
$178.62
1週間の範囲:
$178.38
$178.80
52週間の値動き範囲:
$125.94
$179.00
Masimo Corp Stock (MASI) Company Profile
Compare MASI vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MASI
Masimo Corp
|
178.45 | 9.35B | 1.56B | 216.80M | 206.10M | 1.458 |
ABT
Abbott Laboratories
|
85.60 | 150.32B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
305.09 | 117.93B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
73.81 | 97.02B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
48.31 | 72.99B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.47 | 49.50B | 6.30B | 1.07B | 1.09B | 1.8406 |
Masimo Corp Stock (MASI) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-27 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2025-11-17 | 開始されました | BofA Securities | Neutral |
| 2024-12-27 | 繰り返されました | Raymond James | Outperform |
| 2024-11-06 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2024-06-03 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2024-04-15 | アップグレード | Stifel | Hold → Buy |
| 2024-03-25 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-01-30 | ダウングレード | Jefferies | Buy → Hold |
| 2024-01-03 | ダウングレード | Needham | Buy → Hold |
| 2023-11-08 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-07-18 | ダウングレード | Stifel | Buy → Hold |
| 2023-07-10 | 開始されました | Wells Fargo | Equal Weight |
| 2023-02-22 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2022-12-15 | アップグレード | BTIG Research | Neutral → Buy |
| 2022-12-05 | 繰り返されました | Needham | Buy |
| 2022-10-12 | 開始されました | Jefferies | Buy |
| 2022-09-15 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2022-09-14 | 開始されました | Loop Capital | Buy |
| 2022-04-06 | 開始されました | Wolfe Research | Peer Perform |
| 2022-02-18 | アップグレード | Needham | Hold → Buy |
| 2022-02-16 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2021-10-12 | 再開されました | Raymond James | Mkt Perform |
| 2020-09-02 | 開始されました | Robert W. Baird | Outperform |
| 2020-08-14 | 再開されました | Piper Sandler | Overweight |
| 2020-04-20 | ダウングレード | Needham | Buy → Hold |
| 2020-03-02 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2019-05-07 | 繰り返されました | Needham | Buy |
| 2019-04-16 | ダウングレード | BTIG Research | Buy → Neutral |
| 2019-03-13 | 繰り返されました | Needham | Buy |
| 2018-12-19 | アップグレード | Piper Jaffray | Neutral → Overweight |
| 2018-09-14 | 開始されました | Needham | Buy |
| 2018-03-09 | 開始されました | Barclays | Overweight |
| 2017-08-14 | アップグレード | BTIG Research | Neutral → Buy |
| 2017-04-04 | 繰り返されました | Wedbush | Outperform |
| 2017-03-16 | ダウングレード | Piper Jaffray | Overweight → Neutral |
| 2017-02-27 | 繰り返されました | Wedbush | Outperform |
| 2017-02-13 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2016-08-04 | 繰り返されました | Wedbush | Outperform |
| 2016-05-05 | アップグレード | Piper Jaffray | Neutral → Overweight |
| 2016-05-05 | 繰り返されました | Wedbush | Outperform |
| 2016-01-06 | ダウングレード | Raymond James | Strong Buy → Outperform |
| 2015-08-05 | 繰り返されました | ROTH Capital | Buy |
すべてを表示
Masimo Corp (MASI) 最新ニュース
Masimo earnings in focus as Danaher deal nears close - Investing.com
Masimo Corp at JPMorgan Healthcare Conference Transcript - GuruFocus
Wearables in Pharma & Biotech Research and Forecasts Report 2026-2031, Company Profiles and Market Strategies of Abbott, Dexcom, and Masimo - Yahoo Finance
WATER ISLAND CAPITAL LLC's Masimo Corp(MASI) Holding History - GuruFocus
Masimo Corp stock (US5747951003): earnings, Danaher deal and what’s next for the medical-tech spec - AD HOC NEWS
Danaher Masimo Deal Shifts Growth Outlook And Investor Focus - Yahoo Finance
Pentwater discloses 3.18M-share stake in Masimo (MASI) - Stock Titan
[SCHEDULE 13G] MASIMO CORP Passive Investment Disclosure (>5%) - Stock Titan
Joe Kiani holds 3.66M shares of Masimo (NASDAQ: MASI), cites disputed awards - Stock Titan
MASI Stock Price, Quote & Chart | MASIMO CORP (NASDAQ:MASI) - ChartMill
All eyes on Masimo earnings amid pending Danaher takeover - Investing.com
Swedbank AB Sells 8,000 Shares of Masimo Corporation $MASI - MarketBeat
Comerica Bank Lowers Stock Holdings in Masimo Corporation $MASI - MarketBeat
Masimo Shareholder Notice - TMX Newsfile
Masimo Corporation (MASI) Rose Following the Acquisition Announcement - Yahoo Finance
Masimo Shareholder Action Reminder - TMX Newsfile
Wilson Asset Management International PTY Ltd. Increases Stock Position in Masimo Corporation $MASI - MarketBeat
Masimo Corporation Q1 2026 Financial Results: Revenue, Net Income, and Key Financial Highlights - Minichart
Masimo Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Masimo Corp (FRA:3M4) Stock Price & 30 Year Financial Data - GuruFocus
Masimo : Quarterly Report for Quarter Ending April 4, 2026 (Form 10-Q) - marketscreener.com
Masimo Corp. stockholders adopted Danaher merger agreement May 1 - MLex
Masimo Corp 1Q 2026: Revenue $403.6M, Net income $57.1M, EPS $1.09— 10-Q Summary - TradingView
Danaher to acquire Masimo (NASDAQ: MASI) in $180 per share cash deal - Stock Titan
Masimo Corporation Reports Earnings Results for the First Quarter Ended April 04, 2026 - marketscreener.com
Masimo (MASI) director gets new RSU grant and converts prior award - Stock Titan
Masimo (MASI) director awarded 1,119 RSUs and exercises 1,225 units - Stock Titan
Masimo (MASI) chair exercises 1,225 RSUs and receives 1,119-unit grant - Stock Titan
Masimo (MASI) CHRO nets RSU shares after tax-withholding share disposition - Stock Titan
Vanguard Group Inc. Sells 461,225 Shares of Masimo Corporation $MASI - MarketBeat
Masimo Shareholders Approve $180 Per Share Acquisition by Danaher, Merger Expected to Close in 2026 - Minichart
Masimo shareholders give green light to $10B acquisition by Danaher - MassDevice
Masimo Shareholders Approve $9.9B Sale to Danaher - Orange County Business Journal
Masimo shareholders approve its $9.9B acquisition by Danaher - Modern Healthcare News
Masimo Shareholders OK $9.9B Merger Deal with Danaher - Medical Product Outsourcing
Masimo shareholders approve $180 per share Danaher acquisition - Investing.com
Masimo Shareholders Approve Acquisition by Danaher - marketscreener.com
Masimo (NASDAQ: MASI) shareholders back $180 cash acquisition by Danaher - Stock Titan
Masimo nears Danaher sale after shareholder vote backs cash merger - Stock Titan
Masimo Corporation $MASI Shares Purchased by UBS Group AG - MarketBeat
Is Masimo Corporation (MASI) A Good Stock To Buy Now? - Yahoo Finance
Danaher deal finalized: Company to acquire Masimo for $9.9 billion in cash - MSN
MASI SEC FilingsMasimo Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Masimo (MASI) 10-K/A adds governance, CEO pay terms and Danaher merger plans - Stock Titan
Masimo SET Shows Accurate Pulse Oximetry in Newborns of All Skin Tones - Yahoo Finance
MSN Money - MSN
BlackRock (MASI) holds 116,871 shares of Masimo — 0.2% stake - Stock Titan
Masimo Corporation (NASDAQ:MASI) Short Interest Update - MarketBeat
M&T Bank Corp Purchases 6,578 Shares of Masimo Corporation $MASI - MarketBeat
Danaher Euro Debt Raise Reshapes Masimo Deal And Valuation Story - Yahoo Finance
€2.98B Danaher (NYSE: DHR) euro notes to support Masimo acquisition - Stock Titan
Masimo Corp (MASI) 財務データ
収益
当期純利益
現金流量
EPS
0.59%
1.94%
大文字化:
|
ボリューム (24 時間):